Five-year publication rate of podium presentations at SICOT Annual Conference: an observational study and new objective proposal of conference power by Al-Hourani, Khalid, Al-Aref, Rami, Ley-Greaves, Robert, Ballout, Fatima, Mesfin, Addisu

Get full text

Complement dependency of cardiomyocyte release of mediators during sepsis by Atefi, Gelareh, Zetoune, Firas S., Herron, Todd J., Jalife, José, Bosmann, Markus, Al‐Aref, Rami, Sarma, J. Vidya, Ward, Peter A.

Get full text

Upper Cervical Epidural Abscess in Clinical Practice: Diagnosis and Management by Al-Hourani, Khalid, Al-Aref, Rami, Mesfin, Addisu

Get full text

Astrocyte-conditioned medium attenuates glutamate-induced apoptotic cell death in primary cultured spinal cord neurons of rats by Lu, Xiaojian, Al-Aref, Rami, Zhao, Dong, Shen, Jianhong, Yan, Yaohua, Gao, Yilu

Get full text

Pancreaticoduodenectomy in trauma patients with grade IV–V duodenal or pancreatic injuries: a post hoc analysis of an EAST multicenter trial by Choron, Rachel Leah, Piplani, Charoo, Kuzinar, Julia, Teichman, Amanda L, Bargoud, Christopher, Sciarretta, Jason D, Smith, Randi N, Hanos, Dustin, Afif, Iman N, Beard, Jessica H, Dhillon, Navpreet Kaur, Zhang, Ashling, Ghneim, Mira, Devasahayam, Rebekah, Gunter, Oliver, Smith, Alison A, Sun, Brandi, Cao, Chloe S, Reynolds, Jessica K, Hilt, Lauren A, Holena, Daniel N, Chang, Grace, Jonikas, Meghan, Echeverria-Rosario, Karla, Fung, Nathaniel S, Anderson, Aaron, Fitzgerald, Caitlin A, Dumas, Ryan Peter, Levin, Jeremy H, Trankiem, Christine T, Yoon, JaeHee, Blank, Jacqueline, Hazelton, Joshua P, McLaughlin, Christopher J, Al-Aref, Rami, Kirsch, Jordan Michael, Howard, Daniel S, Scantling, Dane R, Dellonte, Kate, Vella, Michael A, Hopkins, Brent, Shell, Chloe, Udekwu, Pascal, Wong, Evan G, Bellal, Joseph, Lieberman, Howard, Ramsey, Walter A, Stewart, Collin H, Alvarez, Claudia, Berne, John D, Nahmias, Jeffry, Puente, Ivan, Patton, Joe, Rakitin, Ilya, Perea, Lindsey, Pulido, Odessa, Hashim, Ahmed, Keating, Jane, Kodadek, Lisa M, Wade, Jason, Henry, Reynold, Schreiber, Martin, Benjamin, Andrew, Khan, Abid, Mann, Laura K, Mentzer, Caleb, Mousafeiris, Vasileios, Mulita, Francesk, Reid-Gruner, Shari, Sais, Erica, Foote, Christopher W, Palacio, Carlos H, Dias Argandykov, Kaafarani, Haytham, Michelle T Bover Manderski, Moko, Lilamarie, Narayan, Mayur, Seamon, Mark

Get full text

The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms by Gurney, Mark, Chekkaf, Ismahene, Baranwal, Anmol, Basmaci, Rami, Katamesh, Bahga, Greipp, Patricia, Foran, James M., Badar, Talha, Mangaonkar, Abhishek A., Begna, Kebede H., Gangat, Naseema, Patnaik, Mrinal M., Litzow, Mark R., Shah, Mithun V., Viswanatha, David S., He, Rong, Alkhateeb, Hassan B., Al‐Kali, Aref

Get full text

TP53 variant allele frequency and therapy‐related setting independently predict survival in myelodysplastic syndromes with del(5q) by Tefferi, Ayalew, Fleti, Farah, Chan, Onyee, Al Ali, Najla H., Al‐Kali, Aref, Begna, Kebede H., Foran, James M., Badar, Talha, Khera, Nandita, Shah, Mithun, Hiwase, Devendra, Padron, Eric, Sallman, David A., Pardanani, Animesh, Arber, Daniel A., Orazi, Attilio, Reichard, Kaaren K., He, Rong, Ketterling, Rhett P., Gangat, Naseema, Komrokji, Rami

Get full text

Phase 1 study of lenzilumab, a recombinant anti–human GM-CSF antibody, for chronic myelomonocytic leukemia by Patnaik, Mrinal M., Sallman, David A., Mangaonkar, Abhishek A., Heuer, Rachel, Hirvela, Jeffery, Zblewski, Darci, Al-Kali, Aref, Binder, Moritz, Balasis, Maria E., Newman, Hannah, Letson, Christopher, Kruer, Traci L., Gangat, Naseema, Komrokji, Rami S., Tefferi, Ayalew, Lo, Adrian, Shih, Ted, Durrant, Cameron, List, Alan F., Padron, Eric

Get full text

TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases by Fleti, Farah, Chan, Onyee, Singh, Amritpal, Abdelmagid, Maymona G., Al‐Kali, Aref, Elliott, Michelle A., Begna, Kebede H., Foran, James M., Badar, Talha, Khera, Nandita, Al Ali, Najla H., Padron, Eric, Sallman, David A., Shah, Mithun, Hiwase, Devendra, Pardanani, Animesh, Arber, Daniel A., Orazi, Attilio, Reichard, Kaaren K., He, Rong, Ketterling, Rhett P., Gangat, Naseema, Komrokji, Rami, Tefferi, Ayalew

Get full text

Response to erythropoiesis‐stimulating agents in patients with WHO‐defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐R... by Antelo, Guadalupe, Mangaonkar, Abhishek A., Coltro, Giacomo, Buradkar, Ajinkya, Lasho, Terra L., Finke, Christy, Carr, Ryan, Binder, Moritz, Gangat, Naseema, Al‐Kali, Aref, Elliott, Michelle A., King, Rebecca L., Howard, Matthew, Melody, Megan E., Hogan, William, Litzow, Mark R, Tefferi, Ayalew, Fernandez‐Zapico, Martin E., Komrokji, Rami, Patnaik, Mrinal M.

Get full text

ASXL1/TET2 genotype-based risk stratification outperforms ASXL1 mutational impact and is independent of mutant variant allele fractions in chronic myelomonocytic leukemia by Csizmar, Clifford M, Gurney, Mark, Kanagal-Shamanna, Rashmi, Chien, Kelly, Hammond, Danielle, Lasho, Terra L, Finke, Christy M, Dean, Christopher, Natu, Anuya, Mangaonkar, Abhishek A, Al-Kali, Aref, Gangat, Naseema, Tefferi, Ayalew, Alkhateeb, Hassan, Garcia-Manero, Guillermo, Komrokji, Rami S, Ali, Najla A, Padron, Eric, Montalban-Bravo, Guillermo, Patnaik, Mrinal M

Get full text

P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE by Basmaci, Rami, Baranwal, Anmol, He, Rong, Viswanatha, David, Greipp, Patricia, M Foran, James, Arana Yi, Cecilia, Shah, Mithun, Mangaonkar, Abhishek, Litzow, Mark, Hogan, William, Benga, Kebede, Saliba, Antoine, Gangat, Naseema, Tefferi, Ayalew, Patnaik, Mrinal, Al‐Kali, Aref, Alkhateeb, Hassan

Get full text

Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms by Baranwal, Anmol, Gurney, Mark, Basmaci, Rami, Katamesh, Bahga, He, Rong, Viswanatha, David S, Greipp, Patricia, Foran, James, Badar, Talha, Murthy, Hemant, Yi, Cecilia Arana, Palmer, Jeanne, Mangaonkar, Abhishek A, Patnaik, Mrinal M, Litzow, Mark R, Hogan, William J, Begna, Kebede, Gangat, Naseema, Tefferi, Ayalew, Al-Kali, Aref, Shah, Mithun V, Alkhateeb, Hassan B

Get full text

SF3B1 -mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity by Mangaonkar, Abhishek A, Lasho, Terra L, Finke, Christy, Ketterling, Rhett P, Reichard, Kaaren K, McCullough, Kristen, Gangat, Naseema, Al-Kali, Aref, Begna, Kebede H, Hogan, William H, Litzow, Mark R, Alkhateeb, Hassan, Shah, Mithun, Pardanani, Animesh, Tefferi, Ayalew, Al Ali, Najla H, Talati, Chetasi, Sallman, David, Padron, Eric, Komrokji, Rami, Patnaik, Mrinal M

Get full text

Hypomethylating agents in relapsed and refractory AML: outcomes and their predictors in a large international patient cohort by Stahl, Maximilian, DeVeaux, Michelle, Montesinos, Pau, Itzykson, Raphael, Ritchie, Ellen K., Sekeres, Mikkael A., Barnard, John D., Podoltsev, Nikolai A., Brunner, Andrew M., Komrokji, Rami S., Bhatt, Vijaya R., Al-Kali, Aref, Cluzeau, Thomas, Santini, Valeria, Fathi, Amir T., Roboz, Gail J., Fenaux, Pierre, Litzow, Mark R., Perreault, Sarah, Kim, Tae Kon, Prebet, Thomas, Vey, Norbert, Verma, Vivek, Germing, Ulrich, Bergua, Juan Miguel, Serrano, Josefina, Gore, Steven D., Zeidan, Amer M.

Get full text

Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients by Mangaonkar, Abhishek A., Lasho, Terra L., Ketterling, Rhett P., Reichard, Kaaren K., Gangat, Naseema, Al-Kali, Aref, Begna, Kebede H., Pardanani, Animesh, Al Ali, Najla H., Talati, Chetasi, Sallman, David, Padron, Eric, Patnaik, Mrinal M., Tefferi, Ayalew, Komrokji, Rami

Get full text

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms by Steensma, David P., Wermke, Martin, Klimek, Virginia M., Greenberg, Peter L., Font, Patricia, Komrokji, Rami S., Yang, Jay, Brunner, Andrew M., Carraway, Hetty E., Ades, Lionel, Al-Kali, Aref, Alonso-Dominguez, Juan M., Alfonso-Piérola, Ana, Coombs, Catherine C., Deeg, H. Joachim, Flinn, Ian, Foran, James M., Garcia-Manero, Guillermo, Maris, Michael B., McMasters, Malgorzata, Micol, Jean-Baptiste, De Oteyza, Jaime Perez, Thol, Felicitas, Wang, Eunice S., Watts, Justin M., Taylor, Justin, Stone, Richard, Gourineni, Vikram, Marino, Alyssa J., Yao, Huilan, Destenaves, Benoit, Yuan, Xiaobin, Yu, Kun, Dar, Sara, Ohanjanian, Lernik, Kuida, Keisuke, Xiao, Jianjun, Scholz, Catherine, Gualberto, Antonio, Platzbecker, Uwe

Get full text

Somatic TP53 single nucleotide variants, indels and copy number alterations in chronic myelomonocytic leukemia (CMML) by Gurney, Mark, Mangaonkar, Abhishek A., Lasho, Terra, Finke, Christy, Al-Kali, Aref, Gangat, Naseema, Shah, Mithun V., Alkhateeb, Hassan B., Tefferi, Ayalew, Sallman, David, Xie, Zhuoer, Viswanatha, David, Reichard, Kaaren, Al Ali, Najla, Komrokji, Rami, Padron, Eric, Patnaik, Mrinal M.

Get full text

Differential prognostic impact of IDH1 and IDH2 mutations in chronic myelomonocytic leukemia by Walsh, Connor, Hunter, Anthony, Lasho, Terra, Finke, Christy, Ketterling, Rhett, Komrokji, Rami, Tefferi, Ayalew, Mangaonkar, Abhishek, Howard, Matthew, Gangat, Naseema, Al-Kali, Aref, Ali, Najla Al, Padron, Eric, Patnaik, Mrinal M.

Get full text

Venetoclax (VEN) Improves Response Rates but Not Survival in Patients with Chronic Myelomonocytic Leukemia (CMML) Treated with Hypomethylating Agents (HMA): A Multicenter, Propensi... by Tremblay, Douglas, Csizmar, Clifford M, DiNardo, Courtney D., Ball, Somedeb, Rippel, Noa, Hammond, Danielle E., Kadia, Tapan M., Ravandi, Farhad, Chien, Kelly S., Van Hyfte, Grace, Saliba, Antoine, Mangaonkar, Abhishek A, Lasho, Terra L, Al-Kali, Aref, Kremyanskaya, Marina, Feld, Jonathan, Silverman, Lewis R, Komrokji, Rami S., Mascarenhas, John, Padron, Eric, Garcia-Manero, Guillermo, Sallman, David A, Patnaik, Mrinal M., Montalban-Bravo, Guillermo

Get full text